You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 7

April-1 2021 - 262 articles

Cover Story: Testicular germ cell tumors are the most common malignancy of young men, and the incidence is rising worldwide. These tumors are curable with conventional chemotherapy, although a significant number of patients are resistant and die of progressive disease. Epigenetics appears to play an especially important role in the pathogenesis and therapeutic responses of testicular germ cell tumors. Singh et al. review the current evidence that supports a central role for epigenetics in the etiology, progression, and treatment of this common form of testicular cancer. A working model is developed that postulates that epigenetic features that drive testicular cancer malignancy also enable these tumors to be cured at a high rate with chemotherapy. This model provides new insights related to testicular cancer chemoresistance and potential vulnerabilities to epigenetic-based therapies. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (262)

  • Review
  • Open Access
20 Citations
4,952 Views
25 Pages

6 April 2021

Despite multimodal treatment, survival chances for high-risk neuroblastoma patients remain poor. Immunotherapeutic approaches focusing on the activation and/or modification of host immunity for eliminating tumor cells, such as chimeric antigen recept...

  • Article
  • Open Access
5 Citations
4,104 Views
26 Pages

Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix

  • Saioa Mendaza,
  • Joaquín Fernández-Irigoyen,
  • Enrique Santamaría,
  • Imanol Arozarena,
  • David Guerrero-Setas,
  • Tamara Zudaire,
  • Rosa Guarch,
  • August Vidal,
  • José-Santos Salas and
  • Xavier Matias-Guiu
  • + 4 authors

6 April 2021

No therapeutic targets and molecular biomarkers are available in cervical cancer (CC) management. In other cancer types, micro-RNA-877-3p (miR-877-3p) has been associated with events relevant for CC development. Thus, we aimed to determine miR-877-3p...

  • Article
  • Open Access
31 Citations
4,616 Views
14 Pages

Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition

  • John J. Park,
  • Russell J. Diefenbach,
  • Natalie Byrne,
  • Georgina V. Long,
  • Richard A. Scolyer,
  • Elin S. Gray,
  • Matteo S. Carlino and
  • Helen Rizos

6 April 2021

The prognosis for patients with UM is poor, and recent clinical trials have failed to prolong overall survival (OS) of these patients. Over 95% of UM harbor activating driver mutations, and this allows for the investigation of ctDNA. In this study, w...

  • Article
  • Open Access
21 Citations
4,667 Views
24 Pages

Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts

  • Csaba András Schvarcz,
  • Lea Danics,
  • Tibor Krenács,
  • Pedro Viana,
  • Rita Béres,
  • Tamás Vancsik,
  • Ákos Nagy,
  • Attila Gyenesei,
  • József Kun and
  • Marko Fonović
  • + 4 authors

6 April 2021

Modulated electro-hyperthermia (mEHT) is a selective cancer treatment used in human oncology complementing other therapies. During mEHT, a focused electromagnetic field (EMF) is generated within the tumor inducing cell death by thermal and nonthermal...

  • Article
  • Open Access
9 Citations
3,626 Views
10 Pages

Clinical Validation of the Comprehensive Complication Index in Colon Cancer Surgery

  • Nicolò Tamini,
  • Davide Bernasconi,
  • Lorenzo Ripamonti,
  • Giulia Lo Bianco,
  • Marco Braga and
  • Luca Nespoli

6 April 2021

(1) Introduction: To date, the sensitivity of the Comprehensive Complication Index (CCI) in a homogeneous cohort of colonic resections for oncologic purposes has not been reported. The present study aims to compare the CCI with the conventional Clavi...

  • Review
  • Open Access
10 Citations
5,257 Views
27 Pages

Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy

  • Michael Maher,
  • Jeannine Diesch,
  • Marguerite-Marie Le Pannérer and
  • Marcus Buschbeck

6 April 2021

Mutations in genes encoding chromatin regulators are early events contributing to developing asymptomatic clonal hematopoiesis of indeterminate potential and its frequent progression to myeloid diseases with increasing severity. We focus on the subse...

  • Article
  • Open Access
5 Citations
3,811 Views
20 Pages

6 April 2021

Background: Lung cancer is the leading cause of cancer death. SIPA1 is a mitogen induced GTPase activating protein (GAP) and may hamper cell cycle progression. SIPA1 has been shown to be involved in MET signaling and may contribute to tight junction...

  • Review
  • Open Access
22 Citations
4,785 Views
15 Pages

5 April 2021

Advanced gastroesophageal cancer (GEC) has a poor prognosis and limited treatment options. Immunotherapy including the anti-programmed death-1 (PD-1) antibodies pembrolizumab and nivolumab have been approved for use in various treatment settings in G...

  • Review
  • Open Access
18 Citations
4,818 Views
18 Pages

The Role of MicroRNAs in Lung Cancer Metabolism

  • Mohamed Iman Hidayat Nor Azizi,
  • Iekhsan Othman and
  • Rakesh Naidu

5 April 2021

MicroRNAs (miRNAs) are short-strand non-coding RNAs that are responsible for post-transcriptional regulation of many biological processes. Their differential expression is important in supporting tumorigenesis by causing dysregulation in normal biolo...

  • Article
  • Open Access
29 Citations
4,371 Views
18 Pages

Permeability of Hypogymnia physodes Extract Component—Physodic Acid through the Blood–Brain Barrier as an Important Argument for Its Anticancer and Neuroprotective Activity within the Central Nervous System

  • Elżbieta Studzińska-Sroka,
  • Aleksandra Majchrzak-Celińska,
  • Przemysław Zalewski,
  • Dominik Szwajgier,
  • Ewa Baranowska-Wójcik,
  • Marcin Żarowski,
  • Tomasz Plech and
  • Judyta Cielecka-Piontek

5 April 2021

Lichen secondary metabolites are characterized by huge pharmacological potential. Our research focused on assessing the anticancer and neuroprotective activity of Hypogymnia physodes acetone extract (HP extract) and physodic acid, its major component...

of 27

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694